Medical implants such as stents or stent grafts can be used to open blood vessels to mitigate the effects of plaque buildup, as a scaffold to keep embolic material within an aneurysm, as a flow diverter to limit blood flow to certain regions, or for other reasons.
Some implant delivery systems have an outer tubular sheath that contains an elongated “pusher” member on which the implant is disposed. When the distal end of the outer tubular sheath reaches its desired target site, the pusher member can be distally advanced to “push” the implant out of the sheath. In many of these types of delivery systems, the implant is disposed over a portion of the pusher and the pusher further comprises a distal end portion located at or near the distal end of the catheter sheath.
In that regard, as the pusher is distally advance to deploy the implant, the pusher's distal end is advanced well beyond the distal end of the sheath. Depending on the shape and size of the vessel distal of the target site, such distal movement may cause the pusher to contact portions of the vessel beyond the deployed implant. Such contact may result in complications and therefore can be undesirable.
An implant delivery system is described. The implant delivery system can be used for a stent and/or stent graft and/or other implants such as coils, plugs, occluders, or other implants.
One embodiment is directed to a delivery system for a vascular implant, such as a stent, having a pushing mechanism configured to push the stent out of the end of an outer catheter sleeve or sheath without further advancing any portions of the pushing mechanism distally beyond the deployed stent. In other words, even as the stent is deployed, the distal end member of the delivery system remains in a fixed location relative to the outer sheath and the vascular target site in the patient. In this respect, undesirable contact distal of the deployed implant may be reduced or eliminated.
In one embodiment an implant delivery system includes an inner tube and a pusher element.
In another embodiment an implant delivery system includes an inner tube and a pusher element where the pusher element travels over the inner tube.
In another embodiment an implant delivery system includes an inner tube with a fixed position.
In another embodiment an implant delivery system includes an inner tube where the inner tube facilitates placement of a guidewire.
In another embodiment an implant delivery system includes an inner tube with an enlarged distal section.
In another embodiment an implant delivery system includes a pusher element where the pusher element contains one or more recesses to accommodate an implant.
In another embodiment an implant delivery system is used to deliver a stent and/or stent graft.
In another embodiment an implant delivery system is used to deliver a stent and/or stent graft and includes a pusher element. The stent and/or stent graft has a structure which engages with one or more recesses on the pusher element.
In another embodiment an implant delivery system includes a guidewire and a pusher element.
These and other aspects, features and advantages of which embodiments of the invention are capable of will be apparent and elucidated from the following description of embodiments of the present invention, reference being made to the accompanying drawings, in which:
Specific embodiments of the invention will now be described with reference to the accompanying drawings. This invention may, however, be embodied in many different forms and should not be construed as limited to the embodiments set forth herein; rather, these embodiments are provided so that this disclosure will be thorough and complete, and will fully convey the scope of the invention to those skilled in the art. The terminology used in the detailed description of the embodiments illustrated in the accompanying drawings is not intended to be limiting of the invention. In the drawings, like numbers refer to like elements.
As best seen in
Preferably, the outer sheath 105 is similarly fixed in a non-retractable manner relative to the proximal components of the delivery system 100. In other words, the sheath 105 maintains a fixed position relative to the tube 106 and distal end member 102. In that regard, the distal end of the sheath 105 is positioned a proximal distance from the distal end member 102 (or from the largest part of the distal end member 102) so as to create a circumferential gap 101 through which the stent 110 can be pushed through (see
In an alternate embodiment, the sheath 105 can be axially movable relative to the distal end member 102, allowing a portion of the stent 110 to be exposed.
The stent 110 is pushed out of the delivery system 100 by a sliding pusher element 104 that has an internal passage through which the elongated tube 106 is disposed. The pusher element 104 can therefore slide axially along a portion of the tube 106 without also moving the tube 106, distal end member 102, or sheath 105. In other words, the pusher element 104 is independently moveable, allowing the tube 106, distal end member 102, and sheath 105 to have fixed lengths. The pusher element 104 also releasably connects to a proximal end of the stent 110, which allows the pusher element 104 to distally push the stent 110, but also proximally retract the stent 110 prior to its full release and deployment.
Referring to
The depression 104A preferably provides only an axial restraint to the bulb 112. If the depression 104A is large enough, the bulb 112 may also have some vertical movement (perpendicular relative to the axis of the device). However, preferably the overall clearance is limited in order to limit the amount of wasted energy involved in pushing and pulling the implant delivery device 100, as well as to limit the amount of jostling the stent 110 undergoes during delivery.
Radially, the bulb 112 and stent 110 are restrained by the sheath 105 rather than depression 104A. However, other embodiments can utilize a radial limitation within the depression 104A. For example, the depression 104A can take on the shape of a partial sphere with an outward projection (e.g., a partial egg-shape) to restrict the bulb 112 movement in a radial as well as an axial direction.
The stent 110 can be seen further in
In one embodiment, the bulbs 112 of the stent 110 are all located at the same radial position relative to each other. In another embodiment, some of the bulbs 112 are longitudinally offset from each other.
The pusher element 104 is axially moved by a connection to a physician-actuated pusher rod 108. The pusher rod 108 is connected to the pusher element 104 and to a handle 103 at the proximal end of the delivery device 100, allowing the physician to move the handle 103 proximally or distally to thereby move the pusher element 104 proximally or distally. In one embodiment, the pusher rod 108 connects to the pusher element 104 at a location that is radially offset from a center of the pusher element 104, allowing the tube 106 to pass through the center of the pusher element 104 (seen in
The distal end member 102 preferably has an elongated, conical region 102B that proximally increases in diameter to reduce trauma as the delivery device 100 is advanced through the patient. The distal end member 102 also includes a reduced diameter region 102A that increases in diameter in the distal direction, which helps radially expand and direct outwards the distal end of the stent 110 as it is distally advanced within the sheath 105. Optionally, the very proximal portion of the distal end member 102 may also include depressions (similar to depressions 104A) that help maintain the position of the distal bulbs 112 prior to the commencement of the stent 110 deployment. While only three depressions 104A are illustrated, it is contemplated that other numbers of depressions 104A are also possible (e.g., between 1 and 16). Additionally, while the depressions 104A are all illustrated at the same longitudinal position, it is contemplated that some can be longitudinally offset from each other.
The presence of distal end member 102 provides a few benefits. First, it provides an atraumatic surface for minimizing blood vessel trauma during tracking within the vasculature, since the distal end member 102 is preferably made of a soft, polymeric material. Second, the distal end member 102 provides a ramping surface for the implant (i.e., region 102A). When the stent 110 is expelled from the sheath 105, it will open up relatively quickly since the stent 110 is kept in a restrained state due to the compressive force of the sheath 105. Many implants are made of a shape memory material, so they quickly adopt their expanded configuration when released from a sheath 105. Instead of an abrupt opening, the region 102A provides a ramped, controlled opening as the inner surface of the stent 110 contacts the region 102A while the stent 110 is pushed out. Such a controlled delivery is also beneficial to aid retraction. The tendency of an implant to adopt its expanded configuration can result in an abrupt implant opening and therefore the user may not be able to pull the stent back after advancing to a certain point, prohibiting repositionability. As an example, once the majority of the stent 110 is expanded, the opening force can transmit through the rest of the stent 110, propelling it in premature delivery. If the implant opens and is delivered too quickly, there is little time to reposition the implant once a portion of the implant opens. A more controlled delivery therefore allows the user more time and control throughout the delivery process.
The proximal region 102A of distal end member 102 preferably has a relatively abrupt transition region as shown in
The tube 106 and distal end member 102 preferably form a connected passage within their structure that extends from the proximal portion of the delivery device 100 and terminates at the distal end of the distal end member 102. This passage allows the delivery device 100 to be tracked over a guidewire 118 that has been placed at the target delivery location within the patient (see
In
Prior to the enlarged bulbs 112 of the stent 110 leaving the sheath 105, the physician may decide to retract the stent 110 back into the delivery device 100 through gap 101 and redeploy to better achieve a desired stent 110 position. The handle 103 can be retracted proximally, causing the pusher rod 108, the pusher element 104, and the stent 110 to move proximally, recapturing the stent 110 back within the sheath 105. Finally, the stent 110 can be redeployed as noted above until the distal end of the stent 110 (e.g., the bulbs 112) have escaped the sheath 105.
The distal tip member 152 is prevented from moving off the distal end of the tube 106 by stopper 154, which is fixed to the tube 106. As best seen in
As best seen in
In one example, the inner tube 106 can be comprised of a polymer. In another example, the inner tube 106 is metallic.
In one embodiment, the maximum outer diameter of distal end member 102 is equal to or larger than the inner diameter of sheath 105. In one example, the enlarged distal end portion 102, as well as the inner tube 106, are polymeric.
In another embodiment, the inner tube 106 is movable. In this embodiment, a user would separately manipulate the position of inner tube 106 and pusher element 104, since it may be desirable to allow the pusher element 104 to translate relative to the inner tube 106 to limit the amount of the inner tube 104 which is exposed outside the distal end of the sheath 105.
Alternate embodiments can utilize a shorter inner tube 106. The inner tube 106 could traverse only a portion of the overall delivery system length and the sheath 105 would utilize a proximal port to accommodate inner tube 106.
In one example, the overall working length (i.e. length from the proximal end of the sheath 105 to the distal tip of the distal end member 102) is about 90-150 centimeters, while the length of the rapid exchange embodiment (i.e. length from the proximal port 140—which is the starting point of inner tube 106—to the distal tip of the distal end member 102) is about 30-60 centimeters.
Other embodiments are also possible. For example, the pusher could utilize a screw or ratchet system. In this embodiment, the rod would be enclosed within another lumen. The rod and separate lumen would each contain corresponding male-female interfaces to support a ratcheting or screw-type system. The user would interact with knob at the proximal end of the system to push or pull the system. In one example, the knob is comprised of a dial which can be turned in one direction to advance the system and turned in another direction to retract the system. This system could also be automated via an electro-mechanical system where the knob could be turned in one direction to turn a motor to advance or push the system forward, and the knob could be turned in another direction to turn the system in another direction to retract the delivery system.
Pusher element 104 is shown as a round device which sits around inner tube 106. However, the pusher element 104 can take on a number of shapes. It need not completely sit around the inner tube 106 and may instead sit just around a portion of the tube 106 (e.g., a hemisphere). Alternatively, the pusher element 104 can take the form of a slider which slides solely on a circumferential portion of inner tube 106. Obviously, the smaller pusher element 104 is, the smaller the pusher element surface area will be which corresponds to fewer depressions 112 and/or retention structures to grasp the stent 110—however, a smaller pusher element 104 could be useful for a smaller implant where high retention strength is not necessary.
The implant delivery system can be used with a variety of implants, such as stent, stent/grafts, coils, plugs, occluders, etc. Though the system was primarily described with regards to stent and/or stent-grafts, the system can also be with several other devices. For example, the system could work with an embolic coil by having a distal coil implant structure and a connecting piece with an interface which connects to the pusher element 104 (similar to the bulb/depression arrangement of
Though the term sheath or catheter is used in the specification to describe a delivery device which the implant delivery system is delivered through, the implant delivery system can also be tracked through various delivery devices such as hypotubes or other systems which can be used as a vascular conduit which an implant is delivered through.
Though the term inner tube is used to describe element 106 of the figures, the tube 106 can take on a number of different cross-sectional shapes including circular, ellipsoid, square, rectangular, prisms, etc. This list is meant to be non-exhaustive and illustrative.
Although the invention has been described in terms of particular embodiments and applications, one of ordinary skill in the art, in light of this teaching, can generate additional embodiments and modifications without departing from the spirit of or exceeding the scope of the claimed invention. Accordingly, it is to be understood that the drawings and descriptions herein are proffered by way of example to facilitate comprehension of the invention and should not be construed to limit the scope thereof.
This application claims priority to U.S. Provisional Application Ser. No. 62/220,918 filed Sep. 18, 2015 entitled Pushable Implant Delivery System, which is hereby incorporated herein by reference in its entirety.
Number | Name | Date | Kind |
---|---|---|---|
4580568 | Gianturco | Apr 1986 | A |
5534007 | St. Germain | Jul 1996 | A |
5545209 | Roberts | Aug 1996 | A |
5603698 | Roberts | Feb 1997 | A |
5693083 | Baker | Dec 1997 | A |
5733325 | Robinson | Mar 1998 | A |
5824041 | Lenker et al. | Oct 1998 | A |
6019778 | Wilson | Feb 2000 | A |
6368344 | Fitz | Apr 2002 | B1 |
6425916 | Garrison | Jul 2002 | B1 |
6540782 | Snyders | Apr 2003 | B1 |
6623518 | Thompson et al. | Sep 2003 | B2 |
6702843 | Brown | Mar 2004 | B1 |
6776791 | Stallings et al. | Aug 2004 | B1 |
6858034 | Hijlkema | Feb 2005 | B1 |
6936058 | Forde et al. | Aug 2005 | B2 |
6955685 | Escamilla | Oct 2005 | B2 |
7182779 | Acosta | Feb 2007 | B2 |
7309351 | Escamilla et al. | Dec 2007 | B2 |
7510572 | Gabbay | Mar 2009 | B2 |
7740652 | Gerdts | Jun 2010 | B2 |
7771463 | Ton | Aug 2010 | B2 |
7892273 | George | Feb 2011 | B2 |
7942924 | Perez | May 2011 | B1 |
8241344 | Kusleika | Aug 2012 | B2 |
8287582 | Dorn | Oct 2012 | B2 |
8337540 | Callol | Dec 2012 | B2 |
8876876 | Hebert | Nov 2014 | B2 |
8926693 | Duffy | Jan 2015 | B2 |
8968383 | Johnson | Mar 2015 | B1 |
9017393 | Farag | Apr 2015 | B2 |
9023095 | Bueche | May 2015 | B2 |
9072624 | Brown | Jul 2015 | B2 |
9095465 | Kelly | Aug 2015 | B2 |
9198784 | Andreas | Dec 2015 | B2 |
9364314 | Berra | Jun 2016 | B2 |
9387074 | Costello | Jul 2016 | B2 |
9510947 | Straubinger | Dec 2016 | B2 |
9717595 | Costello | Aug 2017 | B2 |
9867611 | Smith | Jan 2018 | B2 |
9872768 | Paul | Jan 2018 | B2 |
9889028 | Rasmussen | Feb 2018 | B2 |
9907650 | Zhang | Mar 2018 | B2 |
9925080 | Arbefeuille | Mar 2018 | B2 |
9949825 | Braido | Apr 2018 | B2 |
9980837 | Clerc | May 2018 | B2 |
9993360 | Shalev | Jun 2018 | B2 |
20010049547 | Moore | Dec 2001 | A1 |
20010049549 | Boylan et al. | Dec 2001 | A1 |
20020016597 | Dwyer | Feb 2002 | A1 |
20020029076 | Yee | Mar 2002 | A1 |
20020055767 | Forde et al. | May 2002 | A1 |
20020120322 | Thompson et al. | Aug 2002 | A1 |
20020120323 | Thompson | Aug 2002 | A1 |
20020183827 | Derus | Dec 2002 | A1 |
20040059407 | Escamilla | Mar 2004 | A1 |
20040087900 | Thompson | May 2004 | A1 |
20040093060 | Seguin | May 2004 | A1 |
20040093061 | Acosta | May 2004 | A1 |
20040158308 | Hogendijk | Aug 2004 | A1 |
20050038494 | Eidenschink | Feb 2005 | A1 |
20050080474 | Andreas | Apr 2005 | A1 |
20050267563 | Case | Dec 2005 | A1 |
20050288764 | Snow | Dec 2005 | A1 |
20060004439 | Spenser | Jan 2006 | A1 |
20060229702 | Agnew | Oct 2006 | A1 |
20060259120 | Vongphakdy | Nov 2006 | A1 |
20070027521 | Andreas | Feb 2007 | A1 |
20070043419 | Nikolchev | Feb 2007 | A1 |
20070100414 | Licata | May 2007 | A1 |
20070100423 | Acosta | May 2007 | A1 |
20070112422 | Dehdashtian | May 2007 | A1 |
20070179587 | Acosta | Aug 2007 | A1 |
20070233222 | Roeder | Oct 2007 | A1 |
20070233224 | Leynov | Oct 2007 | A1 |
20070250151 | Pereira | Oct 2007 | A1 |
20080015674 | Austin | Jan 2008 | A1 |
20080188921 | Yamasaki | Aug 2008 | A1 |
20080262591 | Shin | Oct 2008 | A1 |
20080300667 | Hebert | Dec 2008 | A1 |
20090030497 | Metcalf | Jan 2009 | A1 |
20090264978 | Dieck | Oct 2009 | A1 |
20090287292 | Becking | Nov 2009 | A1 |
20090306760 | Hebert | Dec 2009 | A1 |
20100070015 | Schneider | Mar 2010 | A1 |
20100087906 | Dorn | Apr 2010 | A1 |
20100234932 | Arbefeuille | Sep 2010 | A1 |
20100268328 | Stiger | Oct 2010 | A1 |
20100298931 | Quadri | Nov 2010 | A1 |
20110034987 | Kennedy | Feb 2011 | A1 |
20110190862 | Bashiri | Aug 2011 | A1 |
20110224774 | Silveira | Sep 2011 | A1 |
20110295361 | Claiborne, III | Dec 2011 | A1 |
20110301702 | Rust | Dec 2011 | A1 |
20110307049 | Kao | Dec 2011 | A1 |
20120101561 | Porter | Apr 2012 | A1 |
20120109056 | Rasmussen | May 2012 | A1 |
20120116493 | Harada | May 2012 | A1 |
20120253471 | Tully | Oct 2012 | A1 |
20120316638 | Grad | Dec 2012 | A1 |
20130006348 | Kusleika | Jan 2013 | A1 |
20130178925 | Sugimoto | Jul 2013 | A1 |
20130211493 | Wubbeling | Aug 2013 | A1 |
20130226276 | Newell | Aug 2013 | A1 |
20130226278 | Newell | Aug 2013 | A1 |
20130245745 | Vong | Sep 2013 | A1 |
20130245754 | Blum et al. | Sep 2013 | A1 |
20130274856 | Arbefeuille | Oct 2013 | A1 |
20130282113 | Punga | Oct 2013 | A1 |
20140025154 | Liang | Jan 2014 | A1 |
20140031923 | Rogers | Jan 2014 | A1 |
20140046428 | Cragg | Feb 2014 | A1 |
20140135907 | Gallagher | May 2014 | A1 |
20140135909 | Carr | May 2014 | A1 |
20140180067 | Stigall | Jun 2014 | A1 |
20140180070 | Millett | Jun 2014 | A1 |
20140180383 | Loganathan | Jun 2014 | A1 |
20140200648 | Newell | Jul 2014 | A1 |
20140236278 | Argentine | Aug 2014 | A1 |
20140236279 | Dillon | Aug 2014 | A1 |
20140257456 | Cannon | Sep 2014 | A1 |
20140277332 | Slazas | Sep 2014 | A1 |
20140277345 | Havel | Sep 2014 | A1 |
20140277357 | Slazas | Sep 2014 | A1 |
20140277361 | Farhat | Sep 2014 | A1 |
20140277367 | Cragg | Sep 2014 | A1 |
20140288480 | Zimmerman | Sep 2014 | A1 |
20140364865 | Nishigishi | Dec 2014 | A1 |
20150081000 | Hossainy | Mar 2015 | A1 |
20150081007 | Joye | Mar 2015 | A1 |
20150088245 | Costello | Mar 2015 | A1 |
20150289875 | Consigny | Oct 2015 | A1 |
20150297382 | Tassoni, Jr. | Oct 2015 | A1 |
20150313739 | Hummen | Nov 2015 | A1 |
20160100965 | Nishigishi | Apr 2016 | A1 |
20160262919 | Ondersma | Sep 2016 | A1 |
20160302949 | Nishigishi | Oct 2016 | A1 |
20170056221 | Campbell | Mar 2017 | A1 |
20170056225 | Baxter | Mar 2017 | A1 |
20170172772 | Khenansho | Jun 2017 | A1 |
Number | Date | Country | |
---|---|---|---|
20170079820 A1 | Mar 2017 | US |
Number | Date | Country | |
---|---|---|---|
62220918 | Sep 2015 | US |